Do gabapentin or pregabalin directly modulate the µ receptor?
Background Pregabalin and gabapentin improve neuropathic pain symptoms but there are emerging concerns regarding their misuse. This is more pronounced among patients with substance use disorder, particularly involving opioids. Co-ingestion of gabapentinoids with opioids is increasingly identified in...
主要な著者: | Preeti Manandhar, Bridin Patricia Murnion, Natasha L. Grimsey, Mark Connor, Marina Santiago |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
PeerJ Inc.
2021-04-01
|
シリーズ: | PeerJ |
主題: | |
オンライン・アクセス: | https://peerj.com/articles/11175.pdf |
類似資料
-
Gabapentin and pregabalin exposures reported to United States poison centers, 2012–2022
著者:: Emily J.R. Carter, 等
出版事項: (2024-11-01) -
A Systematic Review of the Clinical Use of Gabapentin and Pregabalin in Bipolar Disorder
著者:: Qin Xiang Ng, 等
出版事項: (2021-08-01) -
Efficacy and safety of pregabalin and gabapentin in spinal stenosis: a systematic review and meta-analysis
著者:: Telmo Martínez, 等
出版事項: (2023-11-01) -
Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids
著者:: Payal H. Desai, PharmD, BCCCP, 等
出版事項: (2021-07-01) -
Gabapentin and Pregabalin in chronic neuropathic pain: cost efficacy evaluation
著者:: Paolo Marchettini, 等
出版事項: (2005-05-01)